Diabetes
Conditions
Interventions
Standard diagnosis and treatment group for doctors:By cluster random method, hospitals with similar clinical levels were randomly divided into 1:1 groups. According to the Guidelines for the Preventio
Intelligent decision support group for doctors:The cluster randomized method was used to incorporate the new comprehensive intervention technology of hospitals with similar clinical levels into the cl
Sponsors
The First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Type 2 diabetes; 2. Age between 40 and 70 years old; 3. Able to accept the artificial intelligence assisted diagnosis and treatment of diabetes management mode; 4. Capable of providing complete medical records, including medical history, medication use, etc; 5. Fully understand the research purpose, nature, and methods, voluntarily enter this study, undergo a 24 month follow-up, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Having severe mental illness or language impairment; 2. Suffering from malignant tumor; 3. Pregnant or lactating women; 4. Individuals with suspected active infections (such as active tuberculosis, pneumonia, etc.); 5. Severe hepatic and renal insufficiency (alanine aminotransferase and/or aspartate aminotransferase > 3 times the upper limit of normal, estimated) glomerular filtration rate (GFR) < 15 mL/min/1.73 m2); 6. Previous history of definite major adverse cardiovascular events and/or undergoing revascularization and/or intravenous thrombolysis Treatment and/or intravascular thrombus removal therapy; 7. Definitely diagnosed non-diabetic retinopathy and non-diabetic nephropathy; 8. Uncontrolled hyperthyroidism or hypothyroidism, pituitary-adrenal dysfunction, and other conditions Endocrine diseases; 9. Alcoholism or drug addiction; 10. Those who, for various reasons (such as personal beliefs, economic factors, etc.), cannot accept new comprehensive intervention technologies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diabetic retinopathy;therosclerosis;Urinary microalbumin/urinary creatinine;blood sugar;HbA1c;islet function;liver function;renal function;lipid; | — |
Countries
China
Contacts
Public ContactZhongyan Shan
The First Hospital of China Medical University
Outcome results
None listed